Interaction of antimicrobial therapy and intestinal flora.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D002701:Chloramphenicol / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000187:drug effects*; D004917:Erythromycin / Q000494:pharmacology; D005664:Furazolidone / Q000494:pharmacology*; D006027:Glycosides / Q000494:pharmacology; D006801:Humans; D007420:Intestine, Large / Q000382:microbiology*; D008034:Lincomycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D006027:Glycosides; D010406:Penicillins; D011113:Polymyxins; D013449:Sulfonamides; D001414:Bacitracin; D009675:Novobiocin; D009268:Nalidixic Acid; D005664:Furazolidone; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D008034:Lincomycin; D013752:Tetracycline